Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.

about

Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift!

P2860

Q42236299-B437CE52-58C4-4592-A72F-D4B035A06BB7 Q54969527-C32E04BB-8E76-4CB8-AEE7-CC61A1983E11

P2860

Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.

Item

http://www.wikidata.org/entity/Q36344204

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.

@ast

Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.

@en

type

Item

label

Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.

@ast

Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.

@en

prefLabel

Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.

@ast

Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.

@en

P1476

Ablative Therapies in Metastatic Breast Cancer: A Systematic Review

@en

P2093

Anand Swaminath

http://www.w3.org/2001/XMLSchema#string

Cindy Walker-Dilks

http://www.w3.org/2001/XMLSchema#string

Laura Banfield

http://www.w3.org/2001/XMLSchema#string

Sameer Parpia

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data.

Optimal search strategies for retrieving scientifically strong studies of diagnosis from Medline: analytical survey.

An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies.

Stereotactic radiosurgery for multiple brain metastases from breast carcinoma.

Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.

Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer.

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article.

P2888

s10549-017-4228-2

P304

13-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-017-4228-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P50

Michael Kucharczyk

P577

2017-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28401364

http://www.w3.org/2001/XMLSchema#string

Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.

about

P2860

P2860

Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698